Curated Research Protocols
Compound Bundles
Protocol-matched compound pairs and stacks — designed around published research synergies. Each bundle ships cold-chain together with full COA documentation.
4
Research stacks
≥99%
Purity verified
COA
Every compound
Recovery Stack
Tissue repair research — the two-compound protocol used in 90%+ of rodent recovery studies.
Compounds Included
Mechanistic Synergy
- BPC-157: VEGFR2 / FAK / NO — angiogenic & proliferative phase
- TB-500: ILK / Akt / NF-κB — anti-inflammatory & actin dynamics
- Non-competing receptors — additive, not antagonistic
Research Protocol
- BPC-157: 10 µg/kg IP daily
- TB-500: 150–600 µg/kg SC 2–3×/week
- Standard cycle: 8–12 weeks
Ref: Sikiric et al. (tendon/ligament); Bock-Marquette et al. Nature 2004
2 compounds · COA included
Items added individually. COA + cold-chain shipping included.
GH Pulse Stack
The gold-standard dual-mechanism GH axis research protocol.
Compounds Included


Mechanistic Synergy
- CJC-1295 No DAC: GHRHr / Gs / cAMP / PKA
- Ipamorelin: GHSR-1a / Gq / IP3 / Ca²⁺ — HPA-clean
- Orthogonal pathways → 8–12× GH amplification (Bowers 1998)
Research Protocol
- CJC-1295 No DAC: 100 mcg/kg SC, 2–3×/day
- Ipamorelin: 100–300 mcg/kg SC, same timing
- Co-inject for maximum synergy; 3–6 month cycles
Ref: Bowers et al. J Clin Endocrinol Metab 1998; Johansen et al. 1999
2 compounds · COA included
Items added individually. COA + cold-chain shipping included.
Longevity Pack
Three orthogonal longevity mechanisms in one curated protocol.
Compounds Included
Mechanistic Synergy
- NAD+: SIRT1/SIRT3 → PGC-1α / SOD2 / mitochondrial biogenesis
- Epitalon: TERT telomerase / AANAT melatonin restoration
- GHK-Cu: Nrf2/Keap1 → GCLC/GSH / TGF-β1 / COL1A1
Research Protocol
- NAD+: 250–500 mg/kg IP (Gomes 2013) or NMN oral
- Epitalon: 1 µg/mouse SC, pulsatile 10-day courses
- GHK-Cu: 1–5 mg/kg/day SC; sterile saline preferred
Ref: Gomes 2013 Cell; Khavinson 2003 TRAP assay; Pickart GHK-Cu gene database
3 compounds · COA included
Items added individually. COA + cold-chain shipping included.
Metabolic Research Kit
Side-by-side GLP-1 mono vs dual agonist comparison — the standard DIO study design.
Compounds Included

Long-acting GLP-1 receptor agonist. Metabolic and appetite regulation research.

Mechanistic Synergy
- Semaglutide: GLP-1R monoagonism (STEP 1: −14.9% BW)
- Tirzepatide: GLP-1R/GIPR dual agonism (SURMOUNT-1: −20.9% BW)
- Head-to-head DIO study design — receptor mechanism dissection
Research Protocol
- Semaglutide: 0.1–1.0 mg/kg SC weekly, DIO C57BL/6J
- Tirzepatide: 0.03–3 mg/kg SC weekly, same model
- Pair-fed vehicle control arm essential
Ref: Wilding 2021 NEJM (STEP 1); Jastreboff 2022 NEJM (SURMOUNT-1)
2 compounds · COA included
Items added individually. COA + cold-chain shipping included.
Why Bundles?
Designed around real research protocols
Protocol-matched
Every bundle maps to a published research methodology — not arbitrary pairings. Synergy is mechanistically justified.
Single cold-chain shipment
All bundle compounds ship together in one insulated package. No fragmented deliveries or staggered cold-chain logistics.
COA for every vial
Each compound in a bundle carries its own lot-specific Certificate of Analysis from Janoshik Analytical — HPLC + MS verified.
Not sure which bundle fits your research?
Use the Protocol Finder quiz to get a personalized compound recommendation.
All compounds sold for research use only (RUO). Not for human or veterinary use. Not for use in food, drugs, or cosmetics. By purchasing you confirm you are a qualified researcher operating within applicable regulations. Terms of Service.




